A Phase II Study To Determine The Biological Effects OfBispecific Antibody MDX H210 (520c9xh22).

Project Details

Short titleA Phase II Study To Determine The Biological Effects OfBispecific Antibody MDX H210 (520c9xh22).
StatusFinished
Effective start/end date1/08/9631/12/00

Funding

  • MEDAREX